Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Voluntary 'pause' in controversial H5N1 virus research lauded

This article was originally published in Scrip

Executive Summary

A month after the US government asked scientists to hold off publishing the details of their research describing a genetically-modified form of the H5N1 avian flu virus, which has been found to be highly transmissible in ferrets, over worries terrorists could use the information for harmful purposes, the researchers agreed to voluntarily "pause" their work for 60 days (scripintelligence, 21 December 2011).

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel